Related Experiment Videos
Effects of platelet-activating factor on rat mesenteric microcirculation
1Department of Pathophysiology, Second Military Medical University, Shanghai, China.
Abstract:
The actions of platelet-activating factor (PAF) on rat mesenteric microcirculation were studied by laser Doppler microscopy in vivo. PAF 0.2 -0.6 micrograms/kg iv produced a dose-related decrease in the blood flow velocity and an increase in the diameters of the mesenteric arterioles and venules. These responses were completely reversed by pretreatment with PAF receptor antagonist SRI 63441. The results suggest that PAF may be a mediator of microcirculatory disturbances in the disease conditions associated with excessive PAF release.
Insights
Platelet-activating factor (PAF) reduces blood flow velocity and widens blood vessels in rats. A PAF receptor antagonist blocked these effects, suggesting PAF
Area of Science:
- Physiology
- Pharmacology
- Microcirculation Research
Background:
- Platelet-activating factor (PAF) is a potent inflammatory mediator.
- Understanding PAF's role in microcirculation is crucial for disease insights.
Purpose of the Study:
- To investigate the in vivo effects of platelet-activating factor (PAF) on rat mesenteric microcirculation.
- To determine if PAF receptor antagonism can reverse PAF-induced changes.
Main Methods:
- In vivo study using laser Doppler microscopy in rats.
- Administration of varying doses of PAF (0.2-0.6 µg/kg IV).
- Assessment of mesenteric arteriole and venule diameter and blood flow velocity.
Main Results:
- PAF induced a dose-dependent decrease in blood flow velocity.
- PAF caused a dose-dependent increase in mesenteric arteriole and venule diameters.
- Pretreatment with PAF receptor antagonist SRI 63441 completely reversed PAF's effects.
Conclusions:
- Platelet-activating factor (PAF) significantly impacts mesenteric microcirculation.
- PAF acts via its specific receptor to mediate these vascular responses.
- PAF may play a role in microcirculatory dysfunction in diseases with excessive PAF release.